# Lilly expects to earn $35.50 to $37.00 per share on an adjusted basis in 2026.

*biotech · news · 2026-04-30 · Reuters*

## Key points

- Lilly raised its 2026 adjusted profit forecast to $35.50-$37.00 per share, exceeding analyst estimates.
- Lilly overtook Novo as the market share leader for GLP-1s in international (ex-US) markets.
- Sales of Mounjaro reached $8.7 billion, over $1 billion higher than expectations.
- Foundayo's U.S. launch saw 3,707 prescriptions in one week, falling short of analyst expectations.

**Companies:** Lilly
**Countries:** United States, India, Switzerland

[Read the full story on Reuters](https://www.reuters.com/business/healthcare-pharmaceuticals/eli-lilly-raises-annual-profit-forecast-sustained-weight-loss-drug-demand-2026-04-30/)

---

Canonical: https://newsio.io/n/19cdbd88-854c-4f9f-aa7d-bb01d4b9b658/lilly-expects-to-earn-35-50-to-37-00-per-share-on-an-adjusted-basis-in-2026-shar
Summarized by Newsio from Reuters. https://newsio.io/how-it-works